Cargando…

Comparative preclinical pharmacokinetics study of 3,3′-diindolylmethane formulations: is personalized treatment and targeted chemoprevention in the horizon?

BACKGROUND: 3,3′-Diindolylmethane (DIM) is known as an agent of natural origin that provides protection against different cancers due to the broad spectrum of its biological activities in vivo. However, this substance has a very poor biodistribution and absorption in animal tissues. This preclinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paltsev, Mikhail, Kiselev, Vsevolod, Muyzhnek, Ekaterina, Drukh, Vadim, Kuznetsov, Igor, Pchelintseva, Olga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029298/ https://www.ncbi.nlm.nih.gov/pubmed/24325835 http://dx.doi.org/10.1186/1878-5085-4-25

Ejemplares similares

Safety and tolerability of DIM-based therapy designed as personalized approach to reverse prostatic intraepithelial neoplasia (PIN)
por: Paltsev, Mikhail, et al.
Publicado: (2014)

Double-blind randomized placebo-controlled multicenter clinical trial (phase IIa) on diindolylmethane’s efficacy and safety in the treatment of CIN: implications for cervical cancer prevention
por: Ashrafian, Levon, et al.
Publicado: (2015)

First results of the double-blind randomized placebo-controlled multicenter clinical trial of DIM-based therapy designed as personalized approach to reverse prostatic intraepithelial neoplasia (PIN)
por: Paltsev, Mikhail, et al.
Publicado: (2016)

Chemopreventive Agent 3,3′-Diindolylmethane Inhibits MDM2 in Colorectal Cancer Cells
por: Gao, Xiang, et al.
Publicado: (2020)

Indoles Derived From Glucobrassicin: Cancer Chemoprevention by Indole-3-Carbinol and 3,3'-Diindolylmethane
por: Williams, David E.
Publicado: (2021)

3,3′-Diindolylmethane and indole-3-carbinol: potential therapeutic molecules for cancer chemoprevention and treatment via regulating cellular signaling pathways
por: Reyes-Hernández, Octavio Daniel, et al.
Publicado: (2023)

3,3′-Diindolylmethane: A Promising Sensitizer of γ-Irradiation
por: Wang, Wenjing, et al.
Publicado: (2015)

Cellular and Molecular Mechanisms of 3,3′-Diindolylmethane in Gastrointestinal Cancer
por: Kim, Soo Mi
Publicado: (2016)

3,3’-Diindolylmethane induces apoptosis and autophagy in fission yeast
por: Emami, Parvaneh, et al.
Publicado: (2021)

Interactions between β-Lactoglobulin and 3,3′-Diindolylmethane in Model System
por: Wang, Cuina, et al.
Publicado: (2019)

Amelioration of Hyperglycemia-Induced Nephropathy by 3,3′-Diindolylmethane in Diabetic Mice
por: Choi, Kyeong-Mi, et al.
Publicado: (2019)

Physicochemical and Microstructural Properties of Polymerized Whey Protein Encapsulated 3,3′-Diindolylmethane Nanoparticles
por: Khan, Abbas, et al.
Publicado: (2019)

3,3′-Diindolylmethane protects cardiomyocytes from LPS-induced inflammatory response and apoptosis
por: Luo, Qiang, et al.
Publicado: (2018)

Targeting Bone Remodeling by Isoflavone and 3,3′-Diindolylmethane in the Context of Prostate Cancer Bone Metastasis
por: Li, Yiwei, et al.
Publicado: (2012)

Role of BioResponse 3,3′-Diindolylmethane in the Treatment of Human Prostate Cancer: Clinical Experience
por: Li, Yiwei, et al.
Publicado: (2016)

Molecular Simulation Studies of 3,3′-Diindolylmethane as a Potent MicroRNA-21 Antagonist
por: Junaid, Md., et al.
Publicado: (2017)

3,3′-Diindolylmethane Enhances Fluorouracil Sensitivity via Inhibition of Pyrimidine Metabolism in Colorectal Cancer
por: Zhang, Jieping, et al.
Publicado: (2022)

3,3′-Diindolylmethane ameliorates renal fibrosis through the inhibition of renal fibroblast activation in vivo and in vitro
por: Xia, Zun-En, et al.
Publicado: (2018)

3,3′-Diindolylmethane (DIM): A Potential Therapeutic Agent against Cariogenic Streptococcus mutans Biofilm
por: Baruch, Yifat, et al.
Publicado: (2023)

Estrogen Induced Metastatic Modulators MMP-2 and MMP-9 Are Targets of 3,3′-Diindolylmethane in Thyroid Cancer
por: Rajoria, Shilpi, et al.
Publicado: (2011)

3,3′-Diindolylmethane Induces G(1) Arrest and Apoptosis in Human Acute T-Cell Lymphoblastic Leukemia Cells
por: Shorey, Lyndsey E., et al.
Publicado: (2012)

A selective aryl hydrocarbon receptor modulator 3,3'-Diindolylmethane inhibits gastric cancer cell growth
por: Yin, Xiao-Fei, et al.
Publicado: (2012)

Sulindac, 3,3’-diindolylmethane and curcumin reduce carcinogenesis in the Pirc rat, an Apc-driven model of colon carcinogenesis
por: Femia, Angelo Pietro, et al.
Publicado: (2015)

3,3′-Diindolylmethane enhances apoptosis in docetaxel-treated breast cancer cells by generation of reactive oxygen species
por: Lanza-Jacoby, Susan, et al.
Publicado: (2018)

The Anticancer Agent 3,3'-Diindolylmethane Inhibits Multispecies Biofilm Formation by Acne-Causing Bacteria and Candida albicans
por: Kim, Yong-Guy, et al.
Publicado: (2022)

Induction of apoptosis in human prostate cancer cell line, PC3, by 3,3′-diindolylmethane through the mitochondrial pathway
por: Nachshon-Kedmi, M, et al.
Publicado: (2004)

Attenuation of Carcinogenesis and the Mechanism Underlying by the Influence of Indole-3-carbinol and Its Metabolite 3,3′-Diindolylmethane: A Therapeutic Marvel
por: Maruthanila, V. L., et al.
Publicado: (2014)

3,3′-Diindolylmethane inhibits the invasion and metastasis of nasopharyngeal carcinoma cells in vitro and in vivo by regulation of epithelial mesenchymal transition
por: WU, TINGTING, et al.
Publicado: (2014)

BRCA1 mRNA levels following a 4–6-week intervention with oral 3,3′-diindolylmethane
por: Kotsopoulos, J, et al.
Publicado: (2014)

3,3’-Diindolylmethane Enhances Paclitaxel Sensitivity by Suppressing DNMT1-Mediated KLF4 Methylation in Breast Cancer
por: Xiang, Fenfen, et al.
Publicado: (2021)

3,3'-Diindolylmethane Enhances Tumor Regression After Radiation Through Protecting Normal Cells to Modulate Antitumor Immunity
por: Li, Lijun, et al.
Publicado: (2020)

3,3'-Diindolylmethane plus Eflornithine suppress DNA Replication and Cell Cycle in Esophageal Squamous Cell Carcinoma in vivo
por: Ma, Fayang, et al.
Publicado: (2022)

Anti-Virulence Activity of 3,3′-Diindolylmethane (DIM): A Bioactive Cruciferous Phytochemical with Accelerated Wound Healing Benefits
por: Golberg, Karina, et al.
Publicado: (2022)

3,3′Diindolylmethane Suppresses Vascular Smooth Muscle Cell Phenotypic Modulation and Inhibits Neointima Formation after Carotid Injury
por: Guan, Hongjing, et al.
Publicado: (2012)

The Indolic Diet-Derivative, 3,3′-Diindolylmethane, Induced Apoptosis in Human Colon Cancer Cells through Upregulation of NDRG1
por: Lerner, A., et al.
Publicado: (2012)

Anticancer effects of 3,3′-diindolylmethane are associated with G1 arrest and mitochondria-dependent apoptosis in human nasopharyngeal carcinoma cells
por: XU, YU, et al.
Publicado: (2013)

Multiple therapeutic and preventive effects of 3,3′-diindolylmethane on cancers including prostate cancer and high grade prostatic intraepithelial neoplasia
por: Zhang, William Weiben, et al.
Publicado: (2014)

Effects of Sulforaphane and 3,3′-Diindolylmethane on Genome-Wide Promoter Methylation in Normal Prostate Epithelial Cells and Prostate Cancer Cells
por: Wong, Carmen P., et al.
Publicado: (2014)

3,3′-Diindolylmethane Protects against Cardiac Hypertrophy via 5′-Adenosine Monophosphate-Activated Protein Kinase-α2
por: Zong, Jing, et al.
Publicado: (2013)

Low levels of 3,3′-diindolylmethane activate estrogen receptor α and induce proliferation of breast cancer cells in the absence of estradiol
por: Marques, Maud, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3knrug3m92vgj55u3h9sq2etlf